Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

The expression of cytokines and their receptors in normal and mildly reactive human brain.

Morris CS, Esiri MM.

J Neuroimmunol. 1998 Dec 1;92(1-2):85-97.

PMID:
9916883
2.
3.

Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions.

Höftberger R, Aboul-Enein F, Brueck W, Lucchinetti C, Rodriguez M, Schmidbauer M, Jellinger K, Lassmann H.

Brain Pathol. 2004 Jan;14(1):43-50.

PMID:
14997936
4.

CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury.

Beschorner R, Nguyen TD, Gözalan F, Pedal I, Mattern R, Schluesener HJ, Meyermann R, Schwab JM.

Acta Neuropathol. 2002 Jun;103(6):541-9. Epub 2002 Jan 30.

PMID:
12012085
5.
6.

CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation.

Fabriek BO, Van Haastert ES, Galea I, Polfliet MM, Döpp ED, Van Den Heuvel MM, Van Den Berg TK, De Groot CJ, Van Der Valk P, Dijkstra CD.

Glia. 2005 Sep;51(4):297-305.

PMID:
15846794
7.
8.

Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude.

Mittelbronn M, Dietz K, Schluesener HJ, Meyermann R.

Acta Neuropathol. 2001 Mar;101(3):249-55.

PMID:
11307625
9.

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.

Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M.

Brain. 2005 Nov;128(Pt 11):2689-704. Epub 2005 Aug 25.

PMID:
16123145
10.

Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.

Simpson J, Rezaie P, Newcombe J, Cuzner ML, Male D, Woodroofe MN.

J Neuroimmunol. 2000 Aug 1;108(1-2):192-200.

PMID:
10900353
11.

Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro.

Ulvestad E, Williams K, Mørk S, Antel J, Nyland H.

J Neuropathol Exp Neurol. 1994 Sep;53(5):492-501.

PMID:
8083690
12.
13.

Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection?

Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE.

Neuropathol Appl Neurobiol. 2005 Jun;31(3):325-38.

PMID:
15885069
14.

Expression of invariant chain and pro-cathepsin L in Alzheimer's brain.

Yoshiyama Y, Arai K, Oki T, Hattori T.

Neurosci Lett. 2000 Aug 25;290(2):125-8.

PMID:
10936693
16.

Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages.

Tripathi S, Maier KG, Bruch D, Kittur DS.

J Surg Res. 2007 Apr;138(2):209-13. Epub 2007 Feb 8.

PMID:
17291534
17.

Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions.

Gobin SJ, Montagne L, Van Zutphen M, Van Der Valk P, Van Den Elsen PJ, De Groot CJ.

Glia. 2001 Oct;36(1):68-77.

PMID:
11571785
18.

Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Komohara Y, Ohnishi K, Kuratsu J, Takeya M.

J Pathol. 2008 Sep;216(1):15-24. doi: 10.1002/path.2370.

PMID:
18553315
19.

Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors.

De Keyser J, Wilczak N, Leta R, Streetland C.

Neurology. 1999 Nov 10;53(8):1628-33.

PMID:
10563603
20.

Cytokines, chemokines, and cytokine receptors in human microglia.

Lee YB, Nagai A, Kim SU.

J Neurosci Res. 2002 Jul 1;69(1):94-103.

PMID:
12111820

Supplemental Content

Support Center